THE MCMANUS GROUP

Lobbying for FULCRUM THERAPEUTICS · Rare disease biopharma company

Filing Registration

1st Quarter (Jan 1 - Mar 31) 2025 · Massachusetts · posted Jan 17, 2025

Lobbying activity 1

Health Issues

Sickle Cell disease education Orphan Drug Tax Credit Priority review vouchers

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem